The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus <i>Acinetobacter baumannii-calcoaceticus</i> Complex

John P. O’Donnell(Entasis Therapeutics (United States)), Sujata M. Bhavnani(Institute for Clinical Pharmacodynamics (United States))
Clinical Infectious Diseases
May 1, 2023
10.1093/cid/ciad096
Cited by 32

Related Papers

Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial
|The Lancet|2025|26
Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I <scp>open‐label</scp> randomized cross‐over study in healthy subjects
|Clinical and Translational Science|2023|6
P-1251. Pharmacometric Analyses to Support Dose Selection of Zoliflodacin, a First-in-Class Oral Antibiotic Being Developed for the Treatment of Uncomplicated Gonorrhea
|Open Forum Infectious Diseases|2025|4